← Eichor
Condition: Solid Tumor Malignancy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Solid Tumor Malignancy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TumorGlow Intraoperative Molecular Imaging (IMI)
Phase 1/Phase 2 · 1 location(s) · University of Pennsylvania · NCT04723810Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
Phase 1 · 1 location(s) · Shanghai Pudong Hospital · NCT06501183A Study of TIL in Advanced Solid Tumors (DFGD)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT06488950INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
Phase 1/Phase 2 · 14 location(s) · University Hospital Heidelberg · NCT03838042A Study of CM350 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Keymed Biosciences Co.Ltd · NCT05263960Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Phase 3 · 4 location(s) · Mayo Clinic · NCT03750227Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
Phase 1/Phase 2 · 1 location(s) · CytosinLab Therapeutics Co., Ltd. · NCT06971523SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid T
Phase 1 · 11 location(s) · Qurgen Inc. · NCT06873659Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02830724A Study of HS-20110 in Participants With Advanced Solid Tumors
Phase 1 · 8 location(s) · Hansoh BioMedical R&D Company · NCT06892379Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
Phase 1 · 3 location(s) · Adlai Nortye Biopharma Co., Ltd. · NCT07252479Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Phase 1/Phase 2 · 11 location(s) · Chipscreen Biosciences, Ltd. · NCT05271292Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Pat
NA · 1 location(s) · Institut Claudius Regaud · NCT06797037Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Co
NA · 1 location(s) · City of Hope Medical Center · NCT05772130A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination T
Phase 1 · 3 location(s) · Atridia Pty Ltd. · NCT07358377A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
Phase 1/Phase 2 · 4 location(s) · Latticon Antibody Therapeutics, Inc · NCT06277219A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind
NA · 2 location(s) · University of Southern California · NCT07332312Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations
Phase 2/Phase 3 · 1 location(s) · The Netherlands Cancer Institute · NCT06279130A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
Phase 1 · 6 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT06487455A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 19 location(s) · Bristol-Myers Squibb · NCT07160725CW-301 FIH Study of CAN016
Phase 1/Phase 2 · 1 location(s) · Canwell Biotech Limited · NCT07664150A Study of WX390 in Patients With Advanced Solid Tumors
Phase 2 · 1 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT06117540Study of CHS-114 in Participants With Advanced Solid Tumors
Phase 1 · 16 location(s) · Coherus Oncology, Inc. · NCT05635643NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors
Phase 1 · 1 location(s) · TCRCure Biopharma Ltd. · NCT05881525Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Phase N/A · 140 location(s) · National Cancer Institute LAO · NCT02474160SKB445 for Injection in Solid Tumors
Phase 1 · 1 location(s) · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · NCT06826040
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.